Mega Lifesciences PCL (BKK:MEGA)
Thailand flag Thailand · Delayed Price · Currency is THB
37.25
-0.25 (-0.67%)
Jul 24, 2026, 4:35 PM ICT

Mega Lifesciences PCL Financials Overview

Millions THB. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
14,39914,19515,38515,71615,72714,172
Revenue Growth
-3.09%-7.74%-2.10%-0.07%10.97%12.36%
Gross Profit
7,5457,4317,7967,1307,0805,947
Operating Income
3,0782,9503,4112,9392,7222,178
Net Income
2,0671,9122,0121,9932,2421,947
Earnings Per Share
2.372.192.312.292.572.23
EPS Growth
4.13%-4.99%0.99%-11.10%15.14%39.79%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Original Equipment Manufacture (OEM)
342.86312.44306.21279.62314.11320.63
Distribution
4,9705,1266,6827,4137,3406,926
Brands
9,0628,7358,3808,0128,0596,915
Unallocated Other Income
24.5821.2917.6910.8613.6510.99
Total
14,39914,19515,38515,71615,72714,172

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4,6374,6443,8582,7222,7992,540
Total Debt
664.32683.54491.24251.84420.87356.33
Net Cash (Debt)
3,9733,9603,3672,4702,3782,184
Net Cash Growth
15.76%17.63%36.31%3.86%8.89%273.44%
Net Cash Per Share
4.564.543.862.832.732.50

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
3,0582,7702,4011,9261,9972,727
Capital Expenditures
-490.01-663.89-247.53-274.65-304.6-151.4
Free Cash Flow
2,5682,1072,1541,6521,6922,575
Free Cash Flow Growth
45.20%-2.20%30.39%-2.38%-34.30%84.62%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
52.40%52.35%50.67%45.37%45.02%41.97%
Operating Margin
21.38%20.78%22.17%18.70%17.30%15.37%
Pretax Margin
18.41%16.94%15.29%14.39%16.50%16.07%
Profit Margin
14.35%13.47%13.08%12.68%14.25%13.74%
FCF Margin
17.84%14.84%14.00%10.51%10.76%18.17%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
1.6001.6001.6001.6001.6001.380
Dividend Per Share Growth
0%0%0%0%15.94%53.33%
Dividend Yield
4.27%4.88%5.18%4.46%3.98%3.30%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
15.7115.2814.4117.6118.1822.62
Forward PE
13.6813.0711.2914.5217.7622.85
P/FCF Ratio
12.6513.8713.4621.2524.0917.10
PS Ratio
2.262.061.882.232.593.11